Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Nio Stock Is in Bubble Territory But There’s More Room to Run

By Josh Enomoto, InvestorPlace Contributor

There’s no denying that Nio stock is one of the top performers of 2020. At the same time, there’s also no denying that shares are starting to enter bubble territory, if they aren’t there already.

Can Cytonics Pivot Successfully to Covid-19 Therapeutics?

By Josh Enomoto, InvestorPlace Contributor

Most equity crowdfunding investors know Cytonics stock as a play on an osteoarthritis solution. However, this could be a big name in the Covid-19 therapeutic search.

Why Science Isn’t Enough for Velodyne

By Josh Enomoto, InvestorPlace Contributor

Velodyne stock is another name to consider for your autonomous portfolio. But one of the biggest risks is that the science is moving too far ahead for societal infrastructures to accommodate.

7 Short-Term Stocks to Make a Quick Buck

By Josh Enomoto, InvestorPlace Contributor

It wasn’t just toilet paper that was in demand when Covid-19 hit us as short-term stocks flew through the roof. But with a second wave upon us, this narrative looks very compelling.

9 Stocks to Buy for a Wild Ride in November

By Josh Enomoto, InvestorPlace Contributor

With rising coronavirus hospitalizations dominating headlines, investors will shift back toward a pandemic mentality. Here are nine stocks to buy to capitalize on this trend.

Kensington Capital Stock Could Be the Ultimate Unicorn Investment

By Josh Enomoto, InvestorPlace Contributor

Kensington Capital stock has garnered interest for its underlying solid-state battery. But this narrative is also incredibly risky.

7 Value Stocks To Buy in an Overvalued Market

By Josh Enomoto, InvestorPlace Contributor

While the coronavirus has brought excitement back to the markets, it’s the contrarian who is eyeballing value stocks that stands to win in the long run.

Improve the Fight Against Cancer with 20/20 GeneSystems Stock

By Josh Enomoto, InvestorPlace Contributor

Few people like talking about cancer, but with 20/20 GeneSystems stock investors have a chance to profit off its mass-scale mitigation.

Why You Can Trust the Switchback Energy Acquisition SPAC to Deliver

By Josh Enomoto, InvestorPlace Contributor

This year may as well be the year of the SPAC, which includes EV charging station investment SBE stock. But diving into the details, this is one reverse merger to believe in.

7 Hotel Stocks to Buy for the Fearless Traveling Investor

By Josh Enomoto, InvestorPlace Contributor

With a pandemic still raging, hotel stocks are in trouble. But if you must be a contrarian, go against the grain with these lodgings.

Load More